ClinicalTrials.gg
Not yet recruitingNCT07210645Updated Nov 20, 2026

Development of a Power Training Program to Improve Mobility in Older Veterans

An interventional study of Gerofit Power Training and Gerofit Standard of Care in Physical Deconditioning and Mobility Decline, sponsored by VA Office of Research and Development. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The overall purpose of this study is to develop a power training intervention in partnership with Veterans participating in Gerofit and to evaluate the program's acceptability, feasibility, and preliminary participant outcomes (leg power, physical function and self-report participation).

Read the detailed description

The overall purpose of this project is to co-design a power training intervention for Veterans engaged in Gerofit and to assess its feasibility, acceptability, and preliminary participant outcomes. Gerofit Veterans and exercise providers will participate in co-designing the power training intervention through interviews and feedback sessions. The power training program developed will be tested in the subsequent randomized feasibility pilot. This pilot aims to evaluate the feasibility, acceptability, and preliminary outcomes of a power training program in older Veterans participating in Gerofit using an explanatory sequential mixed methods design. Veterans newly enrolled in the Gerofit program will be randomized into power training and standard of care groups and will participate in exercise sessions over 6 months. Feasibility and acceptability will be assessed by Veteran adherence to program components and by validated surveys. Quantitative data collection will inform qualitative interviews with Veterans on the acceptability and feasibility of the power training program at its completion. Clinical outcomes will be collected (leg power, physical function, and self-report participation) at baseline, 3 months and 6 months and will be compared between the Gerofit power training and Gerofit standard of care groups. Study findings will lead to the development of a power training program that optimally meets Veteran and Gerofit program needs. In addition, study outcomes will guide implementation of a power training program into Gerofit programs aimed at enhancing mobility outcomes in older Veterans.

02

Conditions studied

  • Physical Deconditioning
  • Mobility Decline

Keywords

  • power training
  • mobility
  • older adult
  • user-centered design
03

In context

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Pilot Study Criteria:

  • Veteran
  • new enrollees of the Rocky Mountain Regional Gerofit Program
  • ability to function independently in a group setting

Exclusion criteria

Exclusion Criteria:

  • inability to perform basic activities of daily living
  • oxygen dependency
  • unstable cardiac disease
  • moderate to severe cognitive impairment ( scores \< 24)
  • proliferative diabetic retinopathy
  • relative exclusions for participation in the in-person Gerofit exercise program including: open wounds, incontinence, and lack of transportation
  • inability to ambulate
  • progressive neurological diagnoses (e.g. Amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis)
  • individuals with planned orthopedic surgeries in the next 3 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Gerofit Power Training Intervention

    This group will be randomized to receive Gerofit power training intervention for 6 months. They will receive power training as part of each Gerofit exercise session. Gerofit exercise sessions also include aerobic, flexibility, and balance training.

    Other: Gerofit Power Training

  • Active comparator
    Gerofit Standard of Care

    This group will be randomized to receive standard of care exercise Gerofit exercise prescription for 6 months. Standard of care exercise for the Gerofit program includes combined aerobic, strength, flexibility and balance training.

    Other: Gerofit Standard of Care

Interventions

  • OtherGerofit Power Training

    Gerofit Power Training will include a power training exercise prescription which will focus on having participants perform concentric portions of each resistance exercise as fast and as safely as possible with the eccentric component performed in a slow and controlled manner. The target dose of the power training intervention is 40-60% of the participant's 1-repetition maximum for 4-6 repetitions across 3-6 sets for each exercise. Exercises will focus on the major groups of the upper and lower body. All other Gerofit program components (balance, aerobic, and flexibility) will be consistent with the standard of care group. Sessions will be the same duration as the standard of care Gerofit group (60-75 minutes). The power training and standard of care groups will only differ in the form of resistance training performed.

  • OtherGerofit Standard of Care

    Gerofit standard of care is a 60-75 minute multimodal exercise program which includes 20-30 minutes of aerobic training, traditional strength training of the major upper and lower body muscle groups (1-3 sets of 8-12 repetitions at moderate load), flexibility training and balance training.

06

What researchers measure

Primary outcomes

  1. Adherence- proportion of Gerofit exercise sessions attended

    Adherence will be measured as a proportion of the number of sessions attended out of the number prescribed per protocol.

    Time frame: assessed at 3-months (primary endpoint) and 6 months in both intervention and standard of care groups

Secondary outcomes

  1. Retention- proportion of Veterans completing the study

    Retention will be tracked as part of feasibility and to inform a future trial. Retention will be measured as the proportion of Veterans who complete all outcome measure timepoints out of the total who complete baseline measures.

    Time frame: assessed at 3-months (primary) and 6 months

  2. Feasibility of the Gerofit exercise program

    Feasibility will be measured through a validated survey: Feasibility of Intervention Measure which consists of 4 items rated on a 5-point Likert scale ranging from (1) completely disagree to (5) complete agree. Higher scores indicate greater feasibility of the program. Measure will only be collected in the intervention group.

    Time frame: assessed at 3-months (primary) and 6 months

  3. Acceptability of the Gerofit exercise program

    Acceptability will be measured through a validated survey: Theoretical Framework of Acceptability Measure which consists of 8 items rated on a 5-point Likert scale ranging from (1) did not like, high burden to (5) strongly liked, low burden. Higher scores indicate greater acceptability of the program. Measure will only be collected in the intervention group.

    Time frame: assessed at 3-months (primary) and 6 months

  4. Leg Press Power

    Leg power will be evaluated using previously validated methods in older adults at 40% and 70% of the Veterans 1-repetition maximum over 5 repetitions. Scores are continuous, higher scores indicate greater leg power (better outcome).

    Time frame: baseline, 3-months and 6 months

  5. 4 stair climb power test (4SCPT)

    Power in Watts will be measured using a valid and reliable test which calculates power from time, body weight and stair height when participants climb 4 steps as fast as possible. Scores are continuous, higher scores indicate greater leg power (better outcome).

    Time frame: baseline, 3-months and 6 months

  6. Gait speed

    This is a functional test of mobility. Participants will be timed while walking at self-selected and fast speeds for 10 meters. Gait speed in meters per second will calculated for self-selected and fast gait speeds. Scores are continuous, higher scores indicate greater greater gait speed and mobility (better outcome).

    Time frame: baseline, 3-months and 6 months

  7. Late Life Function and Disability Instrument (LLFDI)

    Participants will complete this valid and reliable self-report measure of physical function (32 items) and disability (16 items). Raw summary scores are transferred to scaled summary scores on a 0-100 scale with higher scores indicated greater function and greater participation in life tasks.

    Time frame: baseline, 3-months and 6 months

  8. 30 second chair rise

    This is a functional test of leg strength and power. Participants are asked to stand up and sit down as many times as they can in 30 seconds from a standard height chair. Scores are continuous, higher scores indicate greater leg strength and power (better outcome).

    Time frame: baseline, 3-months and 6 months

  9. arm curl test

    This is a functional performance test for upper body strength and is performed on each arm (one arm at a time). It requires the participant to perform as many arm curls (bicep curls) as possible in 30 seconds. Males use an 8lb weight and females use a 5 lb weight. Scores are continuous, and higher scores indicate greater arm strength (better outcome).

    Time frame: baseline, 3-months and 6 months

  10. 6 minute walk test

    This is a functional test of aerobic capacity. Participants walk as far as they can along a preset track in 6 minutes. Score is the maximal distance walked in 6 minutes, measured in meters. Scores are continuous, and higher scores indicate greater aerobic capacity (better outcome).

    Time frame: baseline, 3-months and 6 months

  11. Leg press strength

    This is a test of lower body muscle strength. Participants will perform a 1-repetition maximum leg press test where they press the heaviest load they can 1 time through their full range of motion with good form. The test is scored in pounds. Scores are continuous, and higher scores indicate greater leg strength (better outcome).

    Time frame: baseline, 3-months and 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2027; primary completion for Sep 2030, 41 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2025
First posted
Oct 7, 2025
StartEst.
Apr 1, 2027
Primary completionEst.
Sep 30, 2030
CompletionEst.
Dec 31, 2030
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: identifiers
1 update, last Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Minor edits only
    + 1 other change: identifiers

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07210645
Responsible party
Sponsor
First posted
Oct 7, 2025
Start date
Apr 1, 2027 (estimated)
Primary completion
Sep 30, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Nov 20, 2026

Study contacts

Mattie E Pontiff, PT DPT PhD
Contact
MATTIE.PONTIFF@CUANSCHUTZ.EDU
(337) 578-2252
Jennifer E Stevens-Lapsley, PhD
Contact
Jennifer.Stevens-Lapsley@va.gov
(303) 949-9304
Mattie E Pontiff, PT DPT PhD
principal investigator · Rocky Mountain Regional VA Medical Center, Aurora, CO

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion